Insulin degludec biosimilar (Tonghua Dongbao)
德谷胰岛素生物类似药（通化东宝）
Report date: 2022/09/20 10:13:37
Base Information
Drug NameInsulin degludec biosimilar (Tonghua Dongbao)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTonghua Dongbao Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTonghua Dongbao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A